ProCE Banner Activity

Immune Checkpoint Inhibitors: A New Hope for Patients With Merkel Cell Carcinoma

Clinical Thought
In this commentary, Sandra P. D’Angelo, MD, highlights the practice-changing use of immune checkpoint inhibitor therapy for the treatment of patients with metastatic Merkel cell carcinoma.

Released: November 30, 2016

Expiration: November 29, 2017

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by an educational grant from

Merck KGaA

Pfizer, Inc.